Clinical Trial Update: Resolution Enhancement by a Supplemental Obstruction Lessening Venoactive Drug for Eight Weeks in Deep Vein Thrombosis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update reports eight-week treatment with a venoactive drug for deep vein thrombosis, focusing on resolution enhancement following suppl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis

Drugs mentioned

• A supplemental obstruction lessening venoactive drug

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Deep Vein Thrombosis | Phase 3 | Status: COMPLETED